Pharmacy Times In vitro comparison of dabigatran, unfractionated heparin , and low-molecular weight heparin in preventing thrombus formation on mechanical heart valves. Thromb Res. 2010;126(3):e196-e200. McKellar SH, Abel S, Camp CL, Suri RM, Ereth MH, Schaff HV.
4-traders (press release) NEW YORK, NY -- (Marketwired) -- 10/09/13 -- The Medicines Company (NASDAQ: MDCO) today reported enrollment of the first patient in a Phase III clinical trial comparing the anticoagulant Angiomax® (bivalirudin) to unfractionated heparin (UFH) in ...
Marketwired (press release) NEW YORK, NY--(Marketwired - Oct 9, 2013) - The Medicines Company ( NASDAQ : MDCO) today reported enrollment of the first patient in a Phase ...
